350 related articles for article (PubMed ID: 1687666)
1. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats.
Henselmans JM; Hoogland PV; Stoof JC
Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum.
Henselmans JM; Stoof JC
Brain Res; 1991 Dec; 566(1-2):1-7. PubMed ID: 1687661
[TBL] [Abstract][Full Text] [Related]
3. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
4. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
Ajima A; Yamaguchi T; Kato T
Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of N-methyl-D-aspartate receptors regulating the release of dopamine and acetylcholine from striatal slices.
Cai NS; Kiss B; Erdö SL
J Neurochem; 1991 Dec; 57(6):2148-51. PubMed ID: 1834803
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
Drukarch B; Schepens E; Stoof JC
Neuroscience; 1990; 37(1):1-9. PubMed ID: 1978737
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of D-2 dopamine receptors decreases the evoked in vitro release of [3H]acetylcholine from rat neostriatum: role of K+ and Ca2+.
Drukarch B; Schepens E; Schoffelmeer AN; Stoof JC
J Neurochem; 1989 Jun; 52(6):1680-5. PubMed ID: 2566646
[TBL] [Abstract][Full Text] [Related]
8. Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release.
Bertorelli R; Zambelli M; Di Chiara G; Consolo S
J Neurochem; 1992 Jul; 59(1):353-7. PubMed ID: 1351928
[TBL] [Abstract][Full Text] [Related]
9. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
Töröcsik A; Rakovska A; Görcs T; Vizi ES
Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133
[TBL] [Abstract][Full Text] [Related]
10. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.
Hanania T; Johnson KM
Brain Res; 1999 Oct; 844(1-2):106-17. PubMed ID: 10536266
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
Stoof JC; Verheijden PF; Leysen JE
Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
[TBL] [Abstract][Full Text] [Related]
12. Sustained activation does not desensitize the dopamine D2 receptor-mediated control of evoked in vitro release of radiolabeled acetylcholine from rat striatum.
Drukarch B; Schepens E; Stoof JC
Eur J Pharmacol; 1991 Apr; 196(2):209-12. PubMed ID: 1678719
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation.
Reyneke L; Russell VA; Taljaard JJ
Brain Res; 1990 Nov; 534(1-2):188-94. PubMed ID: 1981481
[TBL] [Abstract][Full Text] [Related]
14. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
Damsma G; Robertson GS; Tham CS; Fibiger HC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
17. No change in neostriatal D-2 dopamine receptors after NMDA lesions of rat prefrontal cortex.
Bridge S; Christie MJ; Beart PM
Pharmacol Biochem Behav; 1986 Jun; 24(6):1829-32. PubMed ID: 2942950
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the role of local anesthetic properties with dopamine uptake blockade in the inhibition of striatal and nucleus accumbens [3H]acetylcholine release by cocaine.
Gifford AN; Johnson KM
J Pharmacol Exp Ther; 1992 Nov; 263(2):757-61. PubMed ID: 1359115
[TBL] [Abstract][Full Text] [Related]
19. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
Rao TS; Correa LD; Lloyd GK
Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640
[TBL] [Abstract][Full Text] [Related]
20. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated.
Cepeda C; Buchwald NA; Levine MS
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9576-80. PubMed ID: 7692449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]